Correlation Between GlaxoSmithKline PLC and Brown Capital
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Brown Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Brown Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and The Brown Capital, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Brown Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Brown Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Brown Capital.
Diversification Opportunities for GlaxoSmithKline PLC and Brown Capital
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Brown is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and The Brown Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brown Capital and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Brown Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brown Capital has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Brown Capital go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Brown Capital
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Brown Capital. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.17 times less risky than Brown Capital. The stock trades about -0.3 of its potential returns per unit of risk. The The Brown Capital is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 7,477 in The Brown Capital on August 30, 2024 and sell it today you would earn a total of 885.00 from holding The Brown Capital or generate 11.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. The Brown Capital
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
Brown Capital |
GlaxoSmithKline PLC and Brown Capital Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and Brown Capital
The main advantage of trading using opposite GlaxoSmithKline PLC and Brown Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Brown Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brown Capital will offset losses from the drop in Brown Capital's long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Brown Capital vs. Pimco Moditiesplus Strategy | Brown Capital vs. International Fund International | Brown Capital vs. Cohen Steers Real | Brown Capital vs. New World Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |